RxDoctor Payments DataLook up a doctor →

Shauntell Kline, NP

Family · Lynchburg, VANPI 1063802312

Payments from drug & device makers

$15,451in general payments, 2019–2025

Across 816 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Amgen$1K
  • Pfizer$1K
  • Abbott$1K
  • plus $6K from 47 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie136$1,965
Novo Nordisk92$1,636
AstraZeneca(2 entities)34$1,584
Amgen75$1,439
Pfizer123$1,267
Abbott41$1,064
Lilly USA, LLC41$766
GSK37$687
Dexcom, Inc.16$494
Boehringer Ingelheim31$452
Johnson & Johnson27$300
Biohaven Pharmaceuticals, Inc.19$262
Esperion Therapeutics, Inc.6$212
Phathom Pharmaceuticals, Inc.5$206
Exact Sciences8$196
Otsuka America Pharmaceutical, Inc.8$191
Astellas Pharma US Inc11$170
Takeda Pharmaceuticals U.S.A., Inc.8$170
Merck4$162
Lundbeck LLC3$153
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$150
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$146
Axsome Therapeutics, Inc.5$137
Supernus Pharmaceuticals, Inc.5$118
SK Life Science, Inc.2$110
Biohaven Pharmaceutical Holding Company Ltd.5$95
Sanofi-aventis U.S. LLC6$95
Corium, LLC5$95
Inspire Medical Systems, Inc.2$91
Argenx US, Inc.1$88
Currax Pharmaceuticals LLC5$80
Biogen1$71
Insightec,inc1$69
E.r. Squibb & Sons, L.L.C.5$68
Bayer4$63
Novartis4$62
Grifols USA, LLC1$58
Amarin Pharma, Inc.3$55
Smith+Nephew1$51
Neurocrine Biosciences, Inc.2$44
Corcept Therapeutics2$42
Eisai Inc.3$41
Xeris Pharmaceuticals, Inc.2$39
Impel Pharmaceuticals Inc.2$33
Antares Pharma, Inc.2$31
CSL Behring1$25
Insulet Corporation1$24
Sanofi1$24
Teva Pharmaceuticals USA, Inc.1$15
Idorsia Pharmaceuticals US Inc1$15
Kowa Pharmaceuticals America, Inc.1$15
Nestle Healthcare Nutrition Inc.1$13
Sanofi Pasteur Inc.1$12

How this compares

$15,451 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia →

Medicare billing

Part B allowed, 2024
$56,919
Medicare patients
142
Services billed
1,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Lynchburg

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →